Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-046022
Filing Date
2024-11-14
Accepted
2024-11-14 17:00:53
Documents
56
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 865648
2 ex31-1.htm EX-31.1 18030
3 ex31-2.htm EX-31.2 17792
4 ex32-1.htm EX-32.1 7405
5 ex32-2.htm EX-32.2 7277
  Complete submission text file 0001493152-24-046022.txt   4424825

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE celc-20240930.xsd EX-101.SCH 31811
7 XBRL CALCULATION FILE celc-20240930_cal.xml EX-101.CAL 46168
8 XBRL DEFINITION FILE celc-20240930_def.xml EX-101.DEF 129701
9 XBRL LABEL FILE celc-20240930_lab.xml EX-101.LAB 333680
10 XBRL PRESENTATION FILE celc-20240930_pre.xml EX-101.PRE 247983
58 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 562922
Mailing Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446
Business Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446 763-392-0767
Celcuity Inc. (Filer) CIK: 0001603454 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38207 | Film No.: 241463983
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)